Combined with our previous result, the OS, PFI, and DSS of LGG, GBM, and pan‐glioma patients with high expression of PTX3 were significantly lower than that of LGG, GBM, pan‐glioma patients with low expression of PTX3, respectively.23 The gene discussed is PTX3; the disease is central nervous system cancer.